News

Why keeping up with data science matters for our health

Why keeping up with data science matters for our health

Data without science is nothing; just 1s and 0s, floating around a cloud waiting for someone to make sense of them. Data science is the process of extracting value from data, using advanced analytics tools. Enormous amounts of health information are being gathered every second, and we are rapidly getting better at decoding it: turning bytes into insights that can be used to improve the lives of patients. But the pace, methods and ethics of data science adoption varies dramatically between countries and regions. Why should we care about keeping up?

Data science is all about creating value from data using advanced new tools. In the health sector, that means creating value for the patient. It enables the extraction of information that can’t be accessed with normal statistics, either because the data sets are too big, disordered, or qualitative instead of quantitative (e.g., with health records or medical imaging).

By bringing together AI tools – such as machine learning, natural language processing and advanced analytics – data science can create new insights, increase efficiency, and smooth processes in the health sector. Many countries around the world are already embracing this evolution in health science, and for good reason!

Discover the whole article on the website of our media partner BIOVOX:

About BioVox

With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!

Sponsors

Contact

Juliette Vanbastelaere

Why keeping up with data science matters for our health Read More »

We are very honoured to count Sanofi among the Sponsors of BioFIT 2021

We are very honoured to count Sanofi among the Sponsors of BioFIT 2021

Many thanks to Sanofi for joining BioFIT 2021 as a Silver Sponsor

Sanofi is a global healthcare leader

At Sanofi, our passion is to prevent, treat and cure illness and disease throughout life. We are driven to improve the health of communities and to find new solutions for patients by combining breakthrough science with advanced technology.
Inspired by the resilience of our patients and strengthened by our heritage, we are always working for new ways to fight chronic, complex and rare diseases with medicines that offer hope for patients and the future of healthcare.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

For more information please visit our website www.sanofi.com.

Join key BioFIT 2021 sponsors such as SanofiMSD, Alzprotect,  Boehringer Ingelheim, Genfit, Pfizer, Roche and Novo Nordisk to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count Sanofi among the Sponsors of BioFIT 2021 Read More »

We are very honoured to count Alzprotect among the Sponsors of BioFIT 2021

We are very honoured to count Alzprotect among the Sponsors of BioFIT 2021

Many thanks to Alzprotect for joining BioFIT 2021 as a Bronze Sponsor

Alzprotect is a biopharmaceutical company that develops drug candidates, from their discovery to clinical trials, for the treatment of neurodegenerative diseases including Alzheimer’s disease (AD) and tauopathies such as Progressive Supranuclear Palsy (PSP).
Alzprotect has developed specific global-level expertise in tauopathies, where neuronal degeneration is a consequence of an abnormal accumulation of hyperphosphorylated Tau proteins combined to neuroinflammation: Progressive Supranuclear Palsy (PSP) and Alzheimer’s disease (AD).
Their expertise led to the discovery of several molecules with novel mechanisms of action, such as AZP2006 that shows potent and promising effects to control neurodegeneration.

Join key BioFIT 2021 sponsors such as MSD, Alzprotect,  Boehringer Ingelheim, Genfit, Pfizer, Roche and Novo Nordisk to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count Alzprotect among the Sponsors of BioFIT 2021 Read More »

Register now for BioFIT 2021 with the Summer offer

Register now for BioFIT 2021 with the Summer offer

Missed the Early Bird offer?
Don’t worry, the Summer offer is here!

10% off the 1st full pass (for BioFIT only or for both BioFIT and MedFIT), then 25% off any additional full pass for the same company

The fees are excl. VAT

Sponsors

Contact

Juliette Vanbastelaere

Register now for BioFIT 2021 with the Summer offer Read More »

We are very honoured to count Novo Nordisk among the Sponsors of BioFIT 2021

We are very honoured to count Novo Nordisk among the Sponsors of BioFIT 2021

Many thanks to Novo Nordisk for joining BioFIT 2021 as a Bronze Sponsor and as a Sponsor of the Start-up Slams

Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. We are committed to the discovery and development of innovative treatments for diabetes, obesity, haemophilia, NASH, atherosclerosis, heart failure, chronic kidney disease and we are seeking partnerships in all these indications. From molecule to market, our focus is on the patient. We are also committed to environmental and social responsibility.

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim, Genfit, MSD and Novo Nordisk to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count Novo Nordisk among the Sponsors of BioFIT 2021 Read More »

We are very honoured to count Roche among the Sponsors of BioFIT 2021

We are very honoured to count Roche among the Sponsors of BioFIT 2021

Many thanks to Roche for joining BioFIT 2021 as a Bronze Sponsor

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to invest heavily in research and development with CHF 11 billion in 2018. Alongside the broad internal pipeline, external innovation has always been a critical component of the Roche research and development strategy.

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim, Genfit, MSD, Roche and Novo Nordisk to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count Roche among the Sponsors of BioFIT 2021 Read More »

We are very honoured to count MSD among the Sponsors of BioFIT 2021

We are very honoured to count MSD among the Sponsors of BioFIT 2021

Many thanks to MSD for joining BioFIT 2021 as a Silver Sponsor

MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs.  Our scientific advances have made a difference in the lives of millions of patients worldwide… and many of these advances were the result of partnerships.  In 2016, more than 60% of our human health sales were attributable to alliance partnerships and patents and we continue to work with our partners in some of the most challenging areas of biomedical research. With more than 100 business development transactions since 2015, our team has experience working on collaborations from discovery to clinical-stage programs regardless of therapeutic area or modality.  We believe that by working together we can play a major role in transforming global health care.  Together we can invent for life.

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim, Genfit, MSD and Novo Nordisk to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count MSD among the Sponsors of BioFIT 2021 Read More »

We are very honoured to count GENFIT among the Sponsors of BioFIT 2021

We are very honoured to count GENFIT among the Sponsors of BioFIT 2021

Many thanks to Genfit for joining BioFIT 2021 as a Bronze Sponsor

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with cholestatic and metabolic chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. GENFIT is currently enrolling in ELATIVE™, a Phase 3 clinical trial evaluating elafibranor* in patients with Primary Biliary Cholangitis (PBC). As part of GENFIT’s comprehensive approach to clinical management of patients with liver disease, the Company is also developing NIS4™, a new, non-invasive blood-based diagnostic technology which could enable easier identification of patients with at-risk NASH. NIS4™ technology has been licensed to LabCorp® in the U.S. and Canada for the development and commercialization of a blood-based molecular diagnostic test powered by NIS4™ technology. Nasdaq and Euronext: GNFT.
* Elafibranor is an investigational compound that has not been reviewed and has not received approval by any regulatory authority

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim and Genfit to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count GENFIT among the Sponsors of BioFIT 2021 Read More »

BioFIT 2021: new dates & format

BioFIT 2021: new dates & format


NEW DATES & FORMAT:
December 7th – 9th, 2021 | Digital event

Dear Community,

Guided by a concern for everyone’s health, BioFIT organisers and its Steering Committee have come to the conclusion that the best option for the upcoming edition of BioFIT was to move forward with a digital format and to extend it to 3 days.

The next edition of BioFIT, initially scheduled to take place in December 2021 in Strasbourg,will therefore be held ONLINE, from December 7th to 9th, 2021.

Given the evolution of the health situation, it seems safer to hold an international event like BioFIT in a 100% digital format this year again.
Indeed, while we are aware that we could expect a return to normal after the summer with vaccination, the uncertainties we are currently still facing regarding sanitary measures and international business travel for the end of the year significantly compromise a proper promotion for our event in a physical format.

Holding the next edition of BioFIT digitally, and announcing it now, will make it easier for our ecosystem to plan their participation in the event and ensure that a critical mass is reached for the 2021 edition.

We are convinced that holding the event in a digital format will be beneficial both in terms of quality and attendance.
Going online will allow us to fulfil our promise: to bring satisfaction to our participants and our partners in terms of meeting opportunities, deals achieved, partnerships launched…
Moreover, in order to enable more meeting opportunities and avoid “zoom-fatigue”, the duration of the event is extended to 3 days rather than 2.

Our choice has been to resort to a high-quality digital solution to offer you an optimal user experience. 
With the same top-notch one-on-one partnering meetings, valuable content and high-level experts, BioFIT Digital continues to safely offer you a unique experience, and to help you drive innovation forward in the sector.

The registration and exhibition fees to the event have been adjusted.

Register now and benefit from the Super Early Bird offer valid until April 29th, 2021!

You can count on our commitment to deliver the upcoming edition of BioFIT in the best conditions and to guide you through this digital configuration.
Please stay tuned for more information on the format, and do not hesitate to contact us if you have any questions.

We look forward to seeing you virtually in December!
Best regards,
The BioFIT team

Sponsors

Contact

Juliette Vanbastelaere

BioFIT 2021: new dates & format Read More »

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2021

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2021

Many thanks to Boehringer Ingelheim for joining BioFIT 2021 as a Bronze Sponsor

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. 

Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention. 

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of 17.5 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 18.1 per cent of net sales. 

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment. 

Join key BioFIT 2021 sponsors such as Boehringer Ingelheim and Genfit to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

Sponsors

Contact

Juliette Vanbastelaere

We are very honoured to count Boehringer Ingelheim among the Sponsors of BioFIT 2021 Read More »

Scroll to Top
  • No products in the cart.